CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 75 filers reported holding CYTEK BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,455 | -16.8% | 2,949,008 | +0.0% | 0.02% | -15.4% |
| Q1 2024 | $19,781 | -26.4% | 2,947,986 | 0.0% | 0.03% | -29.7% |
| Q4 2023 | $26,886 | +107.4% | 2,947,986 | +25.6% | 0.04% | +94.7% |
| Q3 2023 | $12,961 | -7.9% | 2,348,015 | +42.5% | 0.02% | +5.6% |
| Q2 2023 | $14,068 | +11.0% | 1,647,314 | +19.4% | 0.02% | +5.9% |
| Q1 2023 | $12,676 | +50.1% | 1,379,285 | +66.8% | 0.02% | +41.7% |
| Q4 2022 | $8,445 | -99.9% | 827,123 | +30.7% | 0.01% | -7.7% |
| Q3 2022 | $9,318,000 | +1114.9% | 633,007 | +785.5% | 0.01% | +1200.0% |
| Q2 2022 | $767,000 | +0.3% | 71,486 | +0.7% | 0.00% | 0.0% |
| Q1 2022 | $765,000 | +332.2% | 70,954 | +555.2% | 0.00% | – |
| Q4 2021 | $177,000 | +47.5% | 10,829 | +93.4% | 0.00% | – |
| Q3 2021 | $120,000 | – | 5,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |